Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Non-Small-Cell Lung 4Sarcoma, Ewing 2Rhabdomyosarcoma 2Oropharyngeal Neoplasms 2Breast Neoplasms 2Adenocarcinoma 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Squamous Cell Cancer of Head and Neck (SCCHN) 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Prostate Cancer Metastatic 1Prostate Adenocarcinoma 1Pelvic Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Meningioma 1Medulloblastoma 1Malignant Liver Neoplasm 1

Interventions

Low-Level Light Therapy 4Cryotherapy 2Xylitol 1Valacyclovir 1Taurine 1Standard of Care 1Specimen Handling 1Saliva, Artificial 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Practice Guidelines as Topic 1Platinum 1Mouthwashes 1Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin 1Magnetic Resonance Spectroscopy 1Laser Therapy 1Folic Acid 1Dental Prophylaxis 1Control Groups 1Cisplatin 1Betaine 1Acetylcysteine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomatitis × Radiotherapy, Image-Guided × 1 year × Clear all
NCT06532279 2026-05-04

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NRG Oncology

Phase 2 Recruiting
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡